• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NTN4 作为乳腺癌的预后标志物和免疫浸润的标志。

NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer.

机构信息

Joint Laboratory for Translational Medicine Research, Liaocheng People's Hospital, Liaocheng, 252000, China.

出版信息

Sci Rep. 2022 Jun 22;12(1):10567. doi: 10.1038/s41598-022-14575-2.

DOI:10.1038/s41598-022-14575-2
PMID:35732855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9217917/
Abstract

Netrin-4 (NTN4), a member of neurite guidance factor family, can promote neurite growth and elongation. This study aims to investigate if NTN4 correlates with prognosis and immune infiltration in breast cancer. The prognostic landscape of NTN4 and its relationship with immune infiltration in breast cancer were deciphered with public databases and immunohistochemistry (IHC) in tissue samples. The expression profiling and prognostic value of NTN4 were explored using UALCAN, TIMER, Kaplan-Meier Plotter and Prognoscan databases. Based on TIMER, relationships of NTN4 expression with tumor immune invasion and immune cell surface markers were evaluated. Transcription and survival analyses of NTN4 in breast cancer were investigated with cBioPortal database. The STRING database was explored to identify molecular functions and signaling pathways downstream of NTN4. NTN4 expression was significantly lower in invasive breast carcinoma compared with adjacent non-malignant tissues. Promoter methylation of NTN4 exhibited different patterns in breast cancer. Low expression of NTN4 was associated with poorer survival. NTN4 was significantly positively related to infiltration of CD8 T cells, macrophages and neutrophils, whereas significantly negatively related to B cells and tumor purity. Association patterns varied with different subtypes. Various associations between NTN4 levels and immune cell surface markers were revealed. Different subtypes of breast cancer carried different genetic alterations. Mechanistically, NTN4 was involved in mediating multiple biological processes including morphogenesis and migration.

摘要

神经导向因子家族成员 Netrin-4(NTN4)可促进神经突生长和伸长。本研究旨在探讨 NTN4 是否与乳腺癌的预后和免疫浸润相关。通过公共数据库和组织样本免疫组织化学(IHC)解析 NTN4 在乳腺癌中的预后图谱及其与免疫浸润的关系。使用 UALCAN、TIMER、Kaplan-Meier Plotter 和 Prognoscan 数据库探索 NTN4 的表达谱和预后价值。根据 TIMER,评估 NTN4 表达与肿瘤免疫浸润和免疫细胞表面标志物的关系。使用 cBioPortal 数据库研究 NTN4 在乳腺癌中的转录和生存分析。使用 STRING 数据库探索 NTN4 下游的分子功能和信号通路。与相邻非恶性组织相比,浸润性乳腺癌中 NTN4 的表达显著降低。NTN4 的启动子甲基化在乳腺癌中呈现不同的模式。NTN4 低表达与生存率降低相关。NTN4 与 CD8+T 细胞、巨噬细胞和中性粒细胞浸润呈显著正相关,而与 B 细胞和肿瘤纯度呈显著负相关。与不同的亚型有关。揭示了 NTN4 水平与免疫细胞表面标志物之间的各种关联。不同亚型的乳腺癌具有不同的遗传改变。从机制上讲,NTN4 参与介导多种生物学过程,包括形态发生和迁移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/c1bf3dc78a0a/41598_2022_14575_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/111480359dac/41598_2022_14575_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/e68e302c0225/41598_2022_14575_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/9d3e539228cf/41598_2022_14575_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/8ed807c97d98/41598_2022_14575_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/ff6e0af941ad/41598_2022_14575_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/884a15374c87/41598_2022_14575_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/c1bf3dc78a0a/41598_2022_14575_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/111480359dac/41598_2022_14575_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/e68e302c0225/41598_2022_14575_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/9d3e539228cf/41598_2022_14575_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/8ed807c97d98/41598_2022_14575_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/ff6e0af941ad/41598_2022_14575_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/884a15374c87/41598_2022_14575_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f01/9217917/c1bf3dc78a0a/41598_2022_14575_Fig7_HTML.jpg

相似文献

1
NTN4 as a prognostic marker and a hallmark for immune infiltration in breast cancer.NTN4 作为乳腺癌的预后标志物和免疫浸润的标志。
Sci Rep. 2022 Jun 22;12(1):10567. doi: 10.1038/s41598-022-14575-2.
2
NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.NEFM 基因的 DNA 甲基化与乳腺癌的免疫浸润和生存相关。
Clin Epigenetics. 2021 May 17;13(1):112. doi: 10.1186/s13148-021-01096-4.
3
Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins.在一项针对信号序列编码蛋白的筛查中,鉴定NTN4、TRA1和STC2作为乳腺癌的预后标志物。
Clin Cancer Res. 2007 Jun 1;13(11):3164-73. doi: 10.1158/1078-0432.CCR-07-0224.
4
High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.eIF4E 高表达与肿瘤巨噬细胞浸润相关,并导致乳腺癌预后不良。
BMC Cancer. 2021 Dec 7;21(1):1305. doi: 10.1186/s12885-021-09010-0.
5
Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.DRP1 被鉴定为与乳腺癌免疫浸润相关的预后因素。
Int Immunopharmacol. 2020 Dec;89(Pt B):107078. doi: 10.1016/j.intimp.2020.107078. Epub 2020 Oct 10.
6
NTN4 is associated with breast cancer metastasis via regulation of EMT-related biomarkers.NTN4通过调控与上皮-间质转化(EMT)相关的生物标志物与乳腺癌转移相关。
Oncol Rep. 2017 Jan;37(1):449-457. doi: 10.3892/or.2016.5239. Epub 2016 Nov 9.
7
High expression of YEATS2 as a predictive factor of poor prognosis in patients with hepatocellular carcinoma.YEATS2 高表达可作为预测肝细胞癌患者预后不良的因素。
Sci Rep. 2024 Jul 27;14(1):17246. doi: 10.1038/s41598-024-68348-0.
8
Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer.热休克蛋白 90 家族亚型作为预后生物标志物及其与乳腺癌免疫浸润的相关性。
Biomed Res Int. 2020 Oct 21;2020:2148253. doi: 10.1155/2020/2148253. eCollection 2020.
9
ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.ACE2 可能作为乳腺浸润性癌的预后生物标志物。
J Clin Lab Anal. 2022 Jun;36(6):e24362. doi: 10.1002/jcla.24362. Epub 2022 Apr 4.
10
Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.鉴定 GTPase IMAP 家族为乳腺癌肿瘤微环境中的免疫相关预后生物标志物。
Gene. 2022 Feb 20;812:146094. doi: 10.1016/j.gene.2021.146094. Epub 2021 Dec 9.

引用本文的文献

1
Integrating multi-ancestry genomic and proteomic data to identify blood risk biomarkers and target proteins for breast cancer genetic risk loci.整合多血统基因组和蛋白质组数据,以识别乳腺癌遗传风险位点的血液风险生物标志物和靶蛋白。
Int J Cancer. 2025 Jul 14. doi: 10.1002/ijc.70041.
2
Protective Effect of Semaglutide on Obesity-Induced Renal Disease and Obesity-Induced Kidney Renal Clear Cell Carcinoma.司美格鲁肽对肥胖诱导的肾脏疾病及肥胖诱导的肾透明细胞癌的保护作用
Diabetes Metab Syndr Obes. 2025 Mar 19;18:805-818. doi: 10.2147/DMSO.S498447. eCollection 2025.
3
Integrated analysis of spatial transcriptomics and CT phenotypes for unveiling the novel molecular characteristics of recurrent and non-recurrent high-grade serous ovarian cancer.

本文引用的文献

1
eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.eQTL 共定位分析将 NTN4 鉴定为候选乳腺癌风险基因。
Am J Hum Genet. 2020 Oct 1;107(4):778-787. doi: 10.1016/j.ajhg.2020.08.006. Epub 2020 Aug 31.
2
Tumour mutational burden as a biomarker for immunotherapy: Current data and emerging concepts.肿瘤突变负荷作为免疫治疗的生物标志物:当前数据和新兴概念。
Eur J Cancer. 2020 May;131:40-50. doi: 10.1016/j.ejca.2020.02.038. Epub 2020 Apr 9.
3
Advances in theranostic biomarkers for tumor immunotherapy.肿瘤免疫治疗的治疗诊断生物标志物研究进展。
整合空间转录组学和CT表型分析以揭示复发性和非复发性高级别浆液性卵巢癌的新分子特征
Biomark Res. 2024 Aug 12;12(1):80. doi: 10.1186/s40364-024-00632-7.
4
Netrin‑4 promotes VE‑cadherin expression in endothelial cells through the NF‑κB signaling pathway.Netrin-4通过NF-κB信号通路促进内皮细胞中VE-钙黏蛋白的表达。
Exp Ther Med. 2024 Jul 4;28(3):351. doi: 10.3892/etm.2024.12640. eCollection 2024 Sep.
5
EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.EXOSC5 通过调节 NTN4/整合素 β1 信号轴维持子宫内膜癌中的癌症干细胞活性。
Int J Biol Sci. 2024 Jan 1;20(1):265-279. doi: 10.7150/ijbs.86275. eCollection 2024.
6
RNA‑binding protein quaking 5 inhibits the progression of non‑small cell lung cancer by upregulating netrin‑4 expression.RNA 结合蛋白 Quaking5 通过上调轴突导向因子 Netrin-4 的表达抑制非小细胞肺癌的进展。
Oncol Rep. 2023 Nov;50(5). doi: 10.3892/or.2023.8641. Epub 2023 Oct 6.
7
Netrin Family Genes as Prognostic Markers and Therapeutic Targets for Clear Cell Renal Cell Carcinoma: Netrin-4 Acts through the Wnt/β-Catenin Signaling Pathway.神经纤毛蛋白家族基因作为透明细胞肾细胞癌的预后标志物和治疗靶点:神经纤毛蛋白-4通过Wnt/β-连环蛋白信号通路发挥作用。
Cancers (Basel). 2023 May 18;15(10):2816. doi: 10.3390/cancers15102816.
8
Development and Validation of Ferroptosis-Related lncRNAs as Prognosis and Diagnosis Biomarkers for Breast Cancer.铁死亡相关长链非编码 RNA 作为乳腺癌预后和诊断生物标志物的构建与验证。
Biomed Res Int. 2022 Oct 18;2022:2390764. doi: 10.1155/2022/2390764. eCollection 2022.
Curr Opin Chem Biol. 2020 Jun;56:79-90. doi: 10.1016/j.cbpa.2020.02.005. Epub 2020 Mar 24.
4
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer.肿瘤突变负担及免疫、基因组和临床病理因素作为非小细胞肺癌患者接受检查点抑制剂治疗的生物标志物。
Cancer Immunol Immunother. 2020 Jan;69(1):127-134. doi: 10.1007/s00262-019-02446-1. Epub 2019 Dec 6.
5
circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.环状 KIF4A 作为一个预后因素和调节因子来调控三阴性乳腺癌的进展。
Mol Cancer. 2019 Feb 11;18(1):23. doi: 10.1186/s12943-019-0946-x.
6
Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer.转录组分析确定了三阴性乳腺癌与非三阴性乳腺癌之间关键的差异表达基因及临床结果。
Cancer Manag Res. 2018 Dec 21;11:179-190. doi: 10.2147/CMAR.S187151. eCollection 2019.
7
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.STRING v11:具有增强覆盖范围的蛋白质-蛋白质相互作用网络,支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
8
circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression.环状 RNA EPSTI1 作为三阴性乳腺癌进展的预后标志物和介质。
Theranostics. 2018 Jul 1;8(14):4003-4015. doi: 10.7150/thno.24106. eCollection 2018.
9
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.TIMER:用于肿瘤浸润免疫细胞综合分析的网络服务器。
Cancer Res. 2017 Nov 1;77(21):e108-e110. doi: 10.1158/0008-5472.CAN-17-0307.
10
What is precision medicine?精准医学是什么?
Eur Respir J. 2017 Oct 19;50(4). doi: 10.1183/13993003.00391-2017. Print 2017 Oct.